mm mm mm mm mm mm mm
A Guide to Drug Classifications and Dosage
mm mm mm mm mm mm
mm Calculations, mm
4th Edition by Cynthia J. Watkins
mm mm mm mm mm mm
Chapters 1 - 21 mm mm mm mm
,
,Chapter mm1. mmHistory mm of mm Pharmacology
Pharmacology mmClear mmand mmSimple- mmA mmGuide mmto mmDrug mmClassifications mmand mmDosage
mmCalculations mm4thm
mEdition mmWatkins mmTest mmBank
1. A mm nurse m m working m m in mmradiology mm administers m m iodine m m to mm a m m patient m m who mm is
m m having mm a mmcomputedm mtomography mm(CT) m m scan. mm The mm nurse m m working mm on mm the
m m oncology mm unit mmadministers mmchemotherapy mm to m m patients m m who m m have m m cancer.
m m At m m the mm Public m m Health mmDepartment, m m a m m nurse mmadministers m m a m m measles-
mumps-rubella m m (MMR) m m vaccine mmto mma mm 14-month-old mmchild mmas mma mmroutine
mm immunization. mm Which mm branch mm of mmpharmacology mmbest mm describes mmthe mm actions
mm of mmall mmthree mm nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology mmis mmthe mm study mm of mmthe mm biologic mmeffects mm of mm chemicals. m m Nurses
mm are mminvolved mmwith m m clinical m m pharmacology mm or m m pharmacotherapeutics, m m which
m m is mm a mmbranch mm of mmpharmacology mm that m m deals mm with mm the mm uses mm of mm drugs mm to
mm treat, mm prevent, mmand mm diagnose m m disease.m mThe m m radiology mm nurse mm is mmadministering
mm a mm drug mm to mm help mmdiagnose m m a m m disease. mm The mm oncology mmnurse m m is
mm administering mm a mm drug mm to m m help mm treat mma m m disease. m m Pharmacoeconomics
m m includes m m any mmcosts mm involved m m in m m drug m m therapy. mmPharmacodynamics
mm involves mm how mma mm drug mmaffects mm the mmbody mmand mmpharmacokinetics mmis mmhow mmthe
mm body mmacts mmon mm the mm body.
2. A mmphysician mm has mmordered mm intramuscular mm (IM) mm injections mmof
mm morphine, mm a mmnarcotic, mm every mm4 mm hours mm as mm needed mm for mm pain mm in mma
mm motor mm vehicle mm accident mmvictim. mm The mm nurse mm is mm aware m m this mm drug
mm has mm a m m high mm abuse m m potential. mm Under m m whatm
mcategory mmwould
mm morphine mmbe mmclassified?
A) Schedule mm I
B) Schedule mmII
C) Schedule mm III
D) Schedule mmIV
ANSWER: B
, Feedback:
Narcotics mmwith mma mmhigh mmabuse mm potential mmare mmclassified mmas mmSchedule
mm II mmdrugs mmbecause mm of mm severe mm dependence mm liability. m m Schedule m m I
mm drugs mm have mm high mm abuse mmpotential m m and m m no mm accepted m m medical m m use.
m m Schedule m m III m m drugs m m have m m a m m lesser mmabuse m m potential m m than mm II mm and
mm an mm accepted m m medical m m use. m m Schedule m m IV mm drugs mm havem low mmabuse
m
mm potential mmand mm limited mm dependence mm liability.
3. When m m involved m m in m m phase m m III m m drug m m evaluation m m studies, m m what
m m responsibilitiesm
mwould mmthe mmnurse mmhave?
A) Working mm with m m animals m m who m m are m m given m m experimental m m drugs
B) Choosing mm appropriate m m patients m m to mm be mm involved m m in m m the mm drug mm study
C) Monitoring mm and m m observing mm patients m m closely mm for m m adverse m m effects
D) Conducting m m research m m to m m determine m m effectiveness m m of m m the m m drug
ANSWER: C
Feedback:
Phase mm III mm studies mm involve m m use mm of mma mm drug mmin mm a mm vast mm clinical
mm population mm in mm whichm patients mm are m m asked m m to m m record m m any mm symptoms
m
m m they mm experience m m while mm taking m m them mdrugs. mm Nurses mmmay mmbe
mm responsible mm for mm helping mm collect mm and mm analyze mm the mminformation mm to
m m be mm shared mm with mm the mm Food mm and mm Drug mm Administration mm (FDA) m m but
m
mwould m m not m m conduct m m research m m independently mm because m m nurses m m do
m m not m m prescribe mmmedications. mm Use m m of mm animals mm in mm drug mm testing mm is
m m done mm in mm the m m preclinical mm trials. mmSelect mm patients mm who mm are mm involved
mm in mm phase mm II mm studies mm to mm participate mm in mm studies mmwhere mm the
mm participants mm have mm the mm disease m m the mm drug mm is mm intended mm to mm treat.
m m These mmpatients mm are mm monitored mm closely mm for mm drug mm action mm and
mm adverse mm effects. mm Phase mm I mmstudies mm involve mm healthy mm human
mm volunteers mm who mm are mm usually mm paid mm for mm their mmparticipation. mm Nurses
mm may mmobserve mm for mm adverse mm effects mm and mm toxicity.
4. What m m concept m m is mmconsidered m m when m m generic m m drugs m m are
m m substituted m m for m m brandm
mname mmdrugs?
A) Bioavailability
B) Critical m m concentration
C) Distribution
D) Half-life
ANSWER: A
Feedback: